These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12224671)

  • 1. Spironolactone for congestive heart failure.
    Lindbloom EJ; Koenig CJ
    J Fam Pract; 1999 Oct; 48(10):752. PubMed ID: 12224671
    [No Abstract]   [Full Text] [Related]  

  • 2. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
    McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
    Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
    [No Abstract]   [Full Text] [Related]  

  • 3. Heart failure.
    McKelvie R
    Clin Evid; 2002 Jun; (7):57-78. PubMed ID: 12230638
    [No Abstract]   [Full Text] [Related]  

  • 4. Spironolactone in patients with heart failure.
    Fernandez HM; Leipzig RM
    N Engl J Med; 2000 Jan; 342(2):132; author reply 133-4. PubMed ID: 10636750
    [No Abstract]   [Full Text] [Related]  

  • 5. Eplerenone: new drug. Recent myocardial infarction with heart failure: a spironolactone me too.
    Prescrire Int; 2006 Apr; 15(82):46-9. PubMed ID: 16604728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Val-HeFT-Valsartan Heart Failure Trial].
    Haghfelt T
    Ugeskr Laeger; 2001 Mar; 163(13):1867. PubMed ID: 11293319
    [No Abstract]   [Full Text] [Related]  

  • 8. [Beginning therapy of heart failure with beta blockers. Do these patients survive longer?].
    MMW Fortschr Med; 2005 Sep; 147(39):10. PubMed ID: 16245769
    [No Abstract]   [Full Text] [Related]  

  • 9. [Aldosterone blocker in heart failure: life prolonging even in mild symptoms].
    MMW Fortschr Med; 2010 Dec; 152(48):12-3. PubMed ID: 21226226
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of spironolactone in heart failure patients receiving angiotensin-converting enzyme inhibitors and beta-blockers.
    Ahmed A
    J Am Coll Cardiol; 2003 May; 41(10):1851-2. PubMed ID: 12767683
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibitors or beta-blockers in heart failure: does it matter who goes first?
    Fang JC
    Circulation; 2005 Oct; 112(16):2380-2. PubMed ID: 16230494
    [No Abstract]   [Full Text] [Related]  

  • 12. Role and optimal dosing of angiotensin-converting enzyme inhibitors in heart failure.
    Kazi D; Deswal A
    Cardiol Clin; 2008 Feb; 26(1):1-14, v. PubMed ID: 18312901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of heart failure. 2 neurohormone blockers are enough].
    MMW Fortschr Med; 2002 Sep; 144(35-36):57. PubMed ID: 12380364
    [No Abstract]   [Full Text] [Related]  

  • 14. Cross-sectional study of heart failure therapy with angiotensin converting enzyme inhibitors and digoxin.
    Mahmood SA; Hussein GM; Hamza EA
    Saudi Med J; 2004 Aug; 25(8):1060-5. PubMed ID: 15322598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spironolactone in patients with heart failure.
    Vanpee D; Swine C
    N Engl J Med; 2000 Jan; 342(2):133; author reply 133-4. PubMed ID: 10636753
    [No Abstract]   [Full Text] [Related]  

  • 16. Is more better? About dose levels of ACE inhibitors in chronic heart failure.
    Swedberg K
    Eur Heart J; 2000 Dec; 21(23):1902-3. PubMed ID: 11071789
    [No Abstract]   [Full Text] [Related]  

  • 17. The rationale and indications for angiotensin receptor blockers in heart failure.
    Bybee KA; Das S; O'Keefe JH
    Heart Fail Clin; 2006 Jan; 2(1):81-8. PubMed ID: 17386879
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of chronic heart failure with digitalis: are there still indications?].
    Strasser RH
    Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S32-6. PubMed ID: 10535044
    [No Abstract]   [Full Text] [Related]  

  • 19. Triple therapy can achieve striking reductions in frusemide dosage.
    Jolobe OM
    Cardiology; 2009; 114(4):271; author reply 272. PubMed ID: 19684397
    [No Abstract]   [Full Text] [Related]  

  • 20. [Angiotensin-converting enzyme inhibitor dosage in chronic heart insufficiency].
    Villadsen HD; Haghfelt T
    Ugeskr Laeger; 1998 Jun; 160(26):3931-2. PubMed ID: 9656837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.